[Toxicity management for mTOR inhibitors]

MeSH terms

• Humans
• Lung Diseases, Interstitial / chemically induced
• Lung Diseases, Interstitial / drug therapy*
• Molecular Targeted Therapy
• Neoplasms / drug therapy
• Protein Kinase Inhibitors / adverse effects*
• Protein Kinase Inhibitors / therapeutic use
• Stomatitis, Aphthous / chemically induced
• Stomatitis, Aphthous / drug therapy*
• TOR Serine-Threonine Kinases / antagonists & inhibitors*